$522 Million is the total value of Rhenman & Partners Asset Management AB's 108 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VRX | Exit | Valeant Pharmaceuticals Inte | $0 | – | -50,000 | -100.0% | -0.20% | – |
| JNJ | Exit | Johnson & Johnson | $0 | – | -15,000 | -100.0% | -0.28% | – |
| RAD | Exit | Rite Aid Corp | $0 | – | -300,000 | -100.0% | -0.37% | – |
| COO | Exit | Cooper Cos Inc/The | $0 | – | -20,000 | -100.0% | -0.57% | – |
| CEMP | Exit | Cempra Inc | $0 | – | -161,000 | -100.0% | -0.62% | – |
| MCK | Exit | Mckesson Corp | $0 | – | -25,000 | -100.0% | -0.66% | – |
| Exit | Anthem Inc | $0 | – | -67,434 | -100.0% | -1.34% | – | |
| Exit | Medtronic Plc | $0 | – | -169,078 | -100.0% | -2.32% | – | |
| Exit | Gilead Sciences Inc | $0 | – | -207,304 | -100.0% | -2.60% | – | |
| Exit | Pfizer Inc | $0 | – | -555,355 | -100.0% | -2.99% | – | |
| SHPG | Exit | Shire Plcsponsored adr | $0 | – | -409,858 | -100.0% | -4.22% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-01-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.